BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17310994)

  • 1. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases.
    Hausherr A; Tavares R; Schäffer M; Obermeier A; Miksch C; Mitina O; Ellwart J; Hallek M; Krause G
    Oncogene; 2007 Jul; 26(34):4987-98. PubMed ID: 17310994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines.
    Hallek M; Neumann C; Schäffer M; Danhauser-Riedl S; von Bubnoff N; de Vos G; Druker BJ; Yasukawa K; Griffin JD; Emmerich B
    Exp Hematol; 1997 Dec; 25(13):1367-77. PubMed ID: 9406996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells.
    Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J
    Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel signaling pathway associated with Lyn, PI 3-kinase and Akt supports the proliferation of myeloma cells.
    Iqbal MS; Tsuyama N; Obata M; Ishikawa H
    Biochem Biophys Res Commun; 2010 Feb; 392(3):415-20. PubMed ID: 20079716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells.
    Pedranzini L; Dechow T; Berishaj M; Comenzo R; Zhou P; Azare J; Bornmann W; Bromberg J
    Cancer Res; 2006 Oct; 66(19):9714-21. PubMed ID: 17018630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
    Li QF; Wu CT; Duan HF; Sun HY; Wang H; Lu ZZ; Zhang QW; Liu HJ; Wang LS
    Br J Haematol; 2007 Sep; 138(5):632-9. PubMed ID: 17686057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
    Graf D; Kohlmann C; Haselow K; Gehrmann T; Bode JG; Häussinger D
    Hepatology; 2006 Nov; 44(5):1206-17. PubMed ID: 17058237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRC family kinase activity is required for murine embryonic stem cell growth and differentiation.
    Meyn MA; Schreiner SJ; Dumitrescu TP; Nau GJ; Smithgall TE
    Mol Pharmacol; 2005 Nov; 68(5):1320-30. PubMed ID: 15985613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis.
    Ferlin-Bezombes M; Jourdan M; Liautard J; Brochier J; Rossi JF; Klein B
    J Immunol; 1998 Sep; 161(6):2692-9. PubMed ID: 9743325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsaicin inhibits the IL-6/STAT3 pathway by depleting intracellular gp130 pools through endoplasmic reticulum stress.
    Lee HK; Seo IA; Shin YK; Park JW; Suh DJ; Park HT
    Biochem Biophys Res Commun; 2009 May; 382(2):445-50. PubMed ID: 19285962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-activator SRC-1 is dispensable for transcriptional control by STAT3.
    Cvijic H; Bauer K; Löffler D; Pfeifer G; Blumert C; Kretzschmar AK; Henze C; Brocke-Heidrich K; Horn F
    Biochem J; 2009 Apr; 420(1):123-32. PubMed ID: 19203349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis.
    Hodge DR; Xiao W; Peng B; Cherry JC; Munroe DJ; Farrar WL
    Cancer Res; 2005 Jul; 65(14):6255-63. PubMed ID: 16024627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.
    Sawa S; Kamimura D; Jin GH; Morikawa H; Kamon H; Nishihara M; Ishihara K; Murakami M; Hirano T
    J Exp Med; 2006 Jun; 203(6):1459-70. PubMed ID: 16717113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
    Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
    J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
    Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
    Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
    Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
    Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.
    Brocke-Heidrich K; Ge B; Cvijic H; Pfeifer G; Löffler D; Henze C; McKeithan TW; Horn F
    Oncogene; 2006 Nov; 25(55):7297-304. PubMed ID: 16732314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.